Lysosomal membrane integrity in fibroblasts derived from patients with Gaucher disease

Cell Struct Funct. 2024 Jan 23;49(1):1-10. doi: 10.1247/csf.23066. Epub 2023 Dec 9.

Abstract

Gaucher disease (GD) is a recessively inherited lysosomal storage disorder characterized by a deficiency of lysosomal glucocerebrosidase (GBA1). This deficiency results in the accumulation of its substrate, glucosylceramide (GlcCer), within lysosomes. Here, we investigated lysosomal abnormalities in fibroblasts derived from patients with GD. It is noteworthy that the cellular distribution of lysosomes and lysosomal proteolytic activity remained largely unaffected in GD fibroblasts. However, we found that lysosomal membranes of GD fibroblasts were susceptible to damage when exposed to a lysosomotropic agent. Moreover, the susceptibility of lysosomal membranes to a lysosomotropic agent could be partly restored by exogenous expression of wild-type GBA1. Here, we report that the lysosomal membrane integrity is altered in GD fibroblasts, but lysosomal distribution and proteolytic activity is not significantly altered.Key words: glucosylceramide, lysosome, Gaucher disease, lysosomotropic agent.

Keywords: Gaucher disease; glucosylceramide; lysosome; lysosomotropic agent.

MeSH terms

  • Fibroblasts / metabolism
  • Gaucher Disease* / metabolism
  • Glucosylceramides / metabolism
  • Humans
  • Intracellular Membranes / metabolism
  • Lysosomes / metabolism

Substances

  • Glucosylceramides